» Articles » PMID: 27943242

Knockout of a Difficult-to-remove CHO Host Cell Protein, Lipoprotein Lipase, for Improved Polysorbate Stability in Monoclonal Antibody Formulations

Overview
Publisher Wiley
Specialty Biochemistry
Date 2016 Dec 13
PMID 27943242
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

While the majority of host cell protein (HCP) impurities are effectively removed in typical downstream purification processes, a small population of HCPs are particularly challenging. Previous studies have identified HCPs that are challenging for a variety of reasons. Lipoprotein lipase (LPL)-a Chinese hamster ovary (CHO) HCP that functions to hydrolyze esters in triglycerides-was one of ten HCPs identified in previous studies as being susceptible to retention in downstream processing. LPL may degrade polysorbate 80 (PS-80) and polysorbate 20 (PS-20) in final product formulations due to the structural similarity between polysorbates and triglycerides. In this work, recombinant LPL was found to have enzymatic activity against PS-80 and PS-20 in a range of solution conditions that are typical of mAb formulations. LPL knockout CHO cells were created with CRISPR and TALEN technologies and resulting cell culture harvest fluid demonstrated significantly reduced polysorbate degradation without significant impact on cell viability when compared to wild-type samples. Biotechnol. Bioeng. 2017;114: 1006-1015. © 2016 Wiley Periodicals, Inc.

Citing Articles

Polysorbates degrading enzymes in biotherapeutics - a current status and future perspectives.

Felix M, Waerner T, Lakatos D, Reisinger B, Fischer S, Garidel P Front Bioeng Biotechnol. 2025; 12:1490276.

PMID: 39867473 PMC: 11760601. DOI: 10.3389/fbioe.2024.1490276.


Quantitative proteomic analysis of residual host cell protein retention across adeno-associated virus affinity chromatography.

Leibiger T, Min L, Lee K Mol Ther Methods Clin Dev. 2024; 32(4):101383.

PMID: 39691383 PMC: 11650319. DOI: 10.1016/j.omtm.2024.101383.


Analytical Tools for HCP Detection, Identification, and Quantitation.

Kanwal F, Henry M, Meleady P Methods Mol Biol. 2024; 2853:235-248.

PMID: 39460924 DOI: 10.1007/978-1-0716-4104-0_15.


Detection of host cell microprotein impurities in antibody drug products.

Tzani I, Castro-Rivadeneyra M, Kelly P, Strasser L, Zhang L, Clynes M Nat Commun. 2024; 15(1):8605.

PMID: 39366928 PMC: 11452709. DOI: 10.1038/s41467-024-51870-0.


Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations.

Maier M, Weiss L, Zeh N, Schmieder-Todtenhaupt V, Dehghani A, Felix M MAbs. 2024; 16(1):2375798.

PMID: 38984665 PMC: 11238916. DOI: 10.1080/19420862.2024.2375798.


References
1.
Bobik A . Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism. Circulation. 2008; 118(7):702-4. DOI: 10.1161/CIRCULATIONAHA.108.794081. View

2.
Shirai K, Fitzharris T, Shinomiya M, Muntz H, Harmony J, Jackson R . Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism. J Lipid Res. 1983; 24(6):721-30. View

3.
Ran F, Hsu P, Lin C, Gootenberg J, Konermann S, Trevino A . Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013; 154(6):1380-9. PMC: 3856256. DOI: 10.1016/j.cell.2013.08.021. View

4.
Lutz E, Merkel M, Kako Y, Melford K, Radner H, Breslow J . Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. J Clin Invest. 2001; 107(9):1183-92. PMC: 209279. DOI: 10.1172/JCI11774. View

5.
Fu Y, Sander J, Reyon D, Cascio V, Joung J . Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol. 2014; 32(3):279-284. PMC: 3988262. DOI: 10.1038/nbt.2808. View